Skip to main content

Management of T1 Rectal Cancer

  • Chapter
  • First Online:
Difficult Decisions in Colorectal Surgery

Part of the book series: Difficult Decisions in Surgery: An Evidence-Based Approach ((DDSURGERY))

  • 165 Accesses

Abstract

Colorectal cancer is the third most common cancer for both men and women and is the second leading cause of cancer-related deaths in the United States annually. In 2019, it was estimated that 145,600 new colorectal cancer cases were diagnosed in the last year and an estimated 51,020 deaths will have occurred [1]. The treatment for rectal cancer depends on the stage of disease at diagnosis. T1 cancers are defined as those that have grown into the submucosa only. Surgical management of rectal cancer is divided between local and radical resection. Total mesorectal excision (TME) is still considered the gold standard for the curative surgical treatment of rectal cancer. In order to decrease the morbidity associated with a radical resection, several local excision techniques have been developed, but the oncologic outcomes of these resections continue to be questioned. This chapter will explore the management of T1 rectal cancer including presentation and evaluation, operative management approaches, oncologic and quality of life outcomes, as well as review the evidence-based guidelines from both the National Comprehensive Cancer Network (NCCN) and the American Society of Colon and Rectal Surgeons (ASCRS).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. You YN, Hardiman KM, Bafford A, et al. The American Society of Colon and Rectal Surgeons clinical practice guidelines for the Management of Rectal Cancer. Dis Colon Rectum. 2020;63(9):1191–222.

    Article  Google Scholar 

  2. Kudo S, Tamegai Y, Yamano H, et al. Endoscopic mucosal resection of the colon: the Japanese technique. Gastrointest Endosc Clin N Am. 2001;11(3):519–35.

    Article  CAS  Google Scholar 

  3. Marijnen CA, Kapiteijn E, van de Velde CJ, et al. Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol. 2002;20(3):817–25.

    Article  CAS  Google Scholar 

  4. Snijders HS, Wouters MW, van Leersum NJ, et al. Meta-analysis of the risk for anastomotic leakage, the postoperative mortality caused by leakage in relation to the overall postoperative mortality. Eur J Surg Oncol. 2012;38(11):1013–9.

    Article  CAS  PubMed  Google Scholar 

  5. Guillou PJ, Quirke P, Thorpe H, et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet. 2005;365(9472):1718–26.

    Article  Google Scholar 

  6. Hamilton S. Carcinoma of the colon and rectum. Pathology and genetics of tumours of the digestive system. 2000:103–43.

    Google Scholar 

  7. Cooper HS, Deppisch LM, Gourley WK, et al. Endoscopically removed malignant colorectal polyps: clinicopathologic correlations. Gastroenterology. 1995;108(6):1657–65.

    Article  CAS  PubMed  Google Scholar 

  8. Benson AB, Venook AP, Al-Hawary MM, et al. Rectal cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2022;20(10):1139–67.

    Article  CAS  Google Scholar 

  9. Yoshii S, Nojima M, Nosho K, et al. Factors associated with risk for colorectal cancer recurrence after endoscopic resection of T1 tumors. Clin Gastroenterol Hepatol. 2014;12(2):292–302 e293.

    Article  PubMed  Google Scholar 

  10. Tarantino I, Warschkow R, Worni M, et al. Elevated preoperative CEA is associated with worse survival in stage I-III rectal cancer patients. Br J Cancer. 2012;107(2):266–74.

    Article  CAS  PubMed Central  Google Scholar 

  11. Adloff M, Arnaud JP, Bergamaschi R, Schloegel M. Synchronous carcinoma of the colon and rectum: prognostic and therapeutic implications. Am J Surg. 1989;157(3):299–302.

    Article  CAS  PubMed  Google Scholar 

  12. Barillari P, Ramacciato G, De Angelis R, et al. Effect of preoperative colonoscopy on the incidence of synchronous and metachronous neoplasms. Acta Chir Scand. 1990;156(2):163–6.

    CAS  PubMed  Google Scholar 

  13. Bat L, Neumann G, Shemesh E. The association of synchronous neoplasms with occluding colorectal cancer. Dis Colon Rectum. 1985;28(3):149–51.

    Article  CAS  Google Scholar 

  14. Isler JT, Brown PC, Lewis FG, Billingham RP. The role of preoperative colonoscopy in colorectal cancer. Dis Colon Rectum. 1987;30(6):435–9.

    Article  CAS  PubMed  Google Scholar 

  15. Beets-Tan RGH, Lambregts DMJ, Maas M, et al. Magnetic resonance imaging for clinical management of rectal cancer: updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol. 2018;28(4):1465–75.

    Article  PubMed  Google Scholar 

  16. Lahaye MJ, Engelen SM, Nelemans PJ, et al. Imaging for predicting the risk factors—the circumferential resection margin and nodal disease—of local recurrence in rectal cancer: a meta-analysis. Semin Ultrasound CT MR. 2005;26(4):259–68.

    Article  CAS  PubMed  Google Scholar 

  17. Faletti R, Gatti M, Arezzo A, et al. Preoperative staging of rectal cancer using magnetic resonance imaging: comparison with pathological staging. Minerva Chir. 2018;73(1):13–9.

    PubMed  Google Scholar 

  18. Klessen C, Rogalla P, Taupitz M. Local staging of rectal cancer: the current role of MRI. Eur Radiol. 2007;17(2):379–89.

    Article  PubMed  Google Scholar 

  19. Benson AB, Venook AP, Al-Hawary MM, et al. Rectal cancer, version 2.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2018;16(7):874–901.

    Article  Google Scholar 

  20. Xie H, Zhou X, Zhuo Z, et al. Effectiveness of MRI for the assessment of mesorectal fascia involvement in patients with rectal cancer: a systematic review and meta-analysis. Dig Surg. 2014;31(2):123–34.

    Article  PubMed  Google Scholar 

  21. Chaudhri S, Brown L, Hassan I, Horgan AF. Preoperative intensive, community-based vs. traditional stoma education: a randomized, controlled trial. Dis Colon Rectum. 2005;48(3):504–9.

    Article  PubMed  Google Scholar 

  22. Crooks S. Foresight that leads to improved outcome: stoma care nurses’ role in siting stomas. Prof Nurse. 1994;10(2):89–92.

    CAS  PubMed  Google Scholar 

  23. Nash GM, Weiser MR, Guillem JG, et al. Long-term survival after transanal excision of T1 rectal cancer. Dis Colon Rectum. 2009;52(4):577–82.

    Article  PubMed  Google Scholar 

  24. Berger NF, Sylla P. The role of Transanal endoscopic surgery for early rectal cancer. Clin Colon Rectal Surg. 2022;35(2):113–21.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Nascimbeni R, Burgart LJ, Nivatvongs S, Larson DR. Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum. 2002;45(2):200–6.

    Article  PubMed  Google Scholar 

  26. Rogers AC, Winter DC, Heeney A, et al. Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer. Br J Cancer. 2016;115(7):831–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. You YN, Baxter NN, Stewart A, Nelson H. Is the increasing rate of local excision for stage I rectal cancer in the United States justified?: a nationwide cohort study from the National Cancer Database. Ann Surg. 2007;245(5):726–33.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Shaikh I, Askari A, Ouru S, et al. Oncological outcomes of local excision compared with radical surgery after neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and meta-analysis. Int J Color Dis. 2015;30(1):19–29.

    Article  Google Scholar 

  29. Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery—the clue to pelvic recurrence? Br J Surg. 1982;69(10):613–6.

    Article  CAS  PubMed  Google Scholar 

  30. Lindsetmo RO, Joh YG, Delaney CP. Surgical treatment for rectal cancer: an international perspective on what the medical gastroenterologist needs to know. World J Gastroenterol. 2008;14(21):3281–9.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Baxter NN, Garcia-Aguilar J. Organ preservation for rectal cancer. J Clin Oncol. 2007;25(8):1014–20.

    Article  PubMed  Google Scholar 

  32. Yamamoto S, Watanabe M, Hasegawa H, et al. The risk of lymph node metastasis in T1 colorectal carcinoma. Hepato-Gastroenterology. 2004;51(58):998–1000.

    PubMed  Google Scholar 

  33. Seitz U, Bohnacker S, Seewald S, et al. Is endoscopic polypectomy an adequate therapy for malignant colorectal adenomas? Presentation of 114 patients and review of the literature. Dis Colon Rectum. 2004;47(11):1789–96. discussion 1796–1787

    Article  CAS  PubMed  Google Scholar 

  34. Ueno H, Mochizuki H, Hashiguchi Y, et al. Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology. 2004;127(2):385–94.

    Article  PubMed  Google Scholar 

  35. Volk EE, Goldblum JR, Petras RE, Carey WD, Fazio VW. Management and outcome of patients with invasive carcinoma arising in colorectal polyps. Gastroenterology. 1995;109(6):1801–7.

    Article  CAS  Google Scholar 

  36. Maeda K, Koide Y, Katsuno H. When is local excision appropriate for "early" rectal cancer? Surg Today. 2014;44(11):2000–14.

    Article  PubMed  Google Scholar 

  37. Bach SP, Hill J, Monson JR, et al. A predictive model for local recurrence after transanal endoscopic microsurgery for rectal cancer. Br J Surg. 2009;96(3):280–90.

    Article  CAS  PubMed  Google Scholar 

  38. Baron PL, Enker WE, Zakowski MF, Urmacher C. Immediate vs. salvage resection after local treatment for early rectal cancer. Dis Colon Rectum. 1995;38(2):177–81.

    Article  CAS  PubMed  Google Scholar 

  39. Friel CM, Cromwell JW, Marra C, et al. Salvage radical surgery after failed local excision for early rectal cancer. Dis Colon Rectum. 2002;45(7):875–9.

    Article  Google Scholar 

  40. Garcia-Aguilar J, Renfro LA, Chow OS, et al. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial. Lancet Oncol. 2015;16(15):1537–46.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Rullier E, Vendrely V, Asselineau J, et al. Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial. Lancet Gastroenterol Hepatol. 2020;5(5):465–74.

    Article  PubMed  Google Scholar 

  42. Lezoche E, Baldarelli M, Lezoche G, et al. Randomized clinical trial of endoluminal locoregional resection versus laparoscopic total mesorectal excision for T2 rectal cancer after neoadjuvant therapy. Br J Surg. 2012;99(9):1211–8.

    Article  CAS  PubMed  Google Scholar 

  43. Taira T, Nozawa H, Kawai K, et al. Oncological outcomes of pathological T1 lower rectal cancer patients with or without preoperative Chemoradiotherapy. In Vivo. 2020;34(6):3559–64.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Minsky BD. Conservative treatment of rectal cancer with local excision and postoperative radiation therapy. Eur J Cancer. 1995;31A(7–8):1343–6.

    Article  CAS  PubMed  Google Scholar 

  45. Taylor RH, Hay JH, Larsson SN. Transanal local excision of selected low rectal cancers. Am J Surg. 1998;175(5):360–3.

    Article  CAS  Google Scholar 

  46. Lamont JP, McCarty TM, Digan RD, et al. Should locally excised T1 rectal cancer receive adjuvant chemoradiation? Am J Surg. 2000;180(6):402–5. discussion 405–406

    Article  CAS  PubMed  Google Scholar 

  47. Paty PB, Nash GM, Baron P, et al. Long-term results of local excision for rectal cancer. Ann Surg. 2002;236(4):522–9. discussion 529–530

    Article  PubMed Central  Google Scholar 

  48. Borstlap WAA, van Oostendorp SE, Klaver CEL, et al. Organ preservation in rectal cancer: a synopsis of current guidelines. Color Dis. 2017;

    Google Scholar 

  49. Borstlap WA, Tanis PJ, Koedam TW, et al. A multi-centred randomised trial of radical surgery versus adjuvant chemoradiotherapy after local excision for early rectal cancer. BMC Cancer. 2016;16:513.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Balyasnikova S, Read J, Tait D, et al. The results of local excision with or without postoperative adjuvant chemoradiotherapy for early rectal cancer among patients choosing to avoid radical surgery. Color Dis. 2017;19(2):139–47.

    Article  CAS  Google Scholar 

  51. Al-Sawat A, Bae JH, Kim HH, et al. Short- and long-term outcomes of local excision with adjuvant radiotherapy in high-risk T1 rectal cancer patients. Ann Surg Treat Res. 2022;102(1):36–45.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Swanton C, Marcus S, Jayamohan J, et al. Can adjuvant pelvic radiation therapy after local excision or polypectomy for T1 and T2 rectal cancer offer an alternative option to radical surgery? Clin Transl Radiat Oncol. 2021;31:97–101.

    CAS  PubMed  PubMed Central  Google Scholar 

  53. Meyerhardt JA, Mangu PB, Flynn PJ, et al. Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol. 2013;31(35):4465–70.

    Article  Google Scholar 

  54. Morino M, Risio M, Bach S, et al. Early rectal cancer: the European Association for Endoscopic Surgery (EAES) clinical consensus conference. Surg Endosc. 2015;29(4):755–73.

    Article  PubMed  Google Scholar 

  55. Endreseth BH, Myrvold HE, Romundstad P, et al. Transanal excision vs. major surgery for T1 rectal cancer. Dis Colon Rectum. 2005;48(7):1380–8.

    Article  PubMed  Google Scholar 

  56. Garcia-Aguilar J, Mellgren A, Sirivongs P, et al. Local excision of rectal cancer without adjuvant therapy: a word of caution. Ann Surg. 2000;231(3):345–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Mellgren A, Sirivongs P, Rothenberger DA, Madoff RD, Garcia-Aguilar J. Is local excision adequate therapy for early rectal cancer? Dis Colon Rectum. 2000;43(8):1064–71. discussion 1071–1064

    Article  CAS  PubMed  Google Scholar 

  58. Chorost MI, Petrelli NJ, McKenna M, Kraybill WG, Rodriguez-Bigas MA. Local excision of rectal carcinoma. Am Surg. 2001;67(8):774–9.

    Article  CAS  PubMed  Google Scholar 

  59. van Oostendorp SE, Smits LJH, Vroom Y, et al. Local recurrence after local excision of early rectal cancer: a meta-analysis of completion TME, adjuvant (chemo)radiation, or no additional treatment. Br J Surg. 2020;107(13):1719–30.

    Article  PubMed  Google Scholar 

  60. Madbouly KM, Remzi FH, Erkek BA, et al. Recurrence after transanal excision of T1 rectal cancer: should we be concerned? Dis Colon Rectum. 2005;48(4):711–9. discussion 719–721

    Article  PubMed  Google Scholar 

  61. Tanaka S, Asayama N, Shigita K, et al. Towards safer and appropriate application of endoscopic submucosal dissection for T1 colorectal carcinoma as total excisional biopsy: future perspectives. Dig Endosc. 2015;27(2):216–22.

    Article  PubMed  Google Scholar 

  62. Kawachi H, Eishi Y, Ueno H, et al. A three-tier classification system based on the depth of submucosal invasion and budding/sprouting can improve the treatment strategy for T1 colorectal cancer: a retrospective multicenter study. Mod Pathol. 2015;28(6):872–9.

    Article  PubMed  Google Scholar 

  63. Kitajima K, Fujimori T, Fujii S, et al. Correlations between lymph node metastasis and depth of submucosal invasion in submucosal invasive colorectal carcinoma: a Japanese collaborative study. J Gastroenterol. 2004;39(6):534–43.

    Article  PubMed  Google Scholar 

  64. Asayama N, Oka S, Tanaka S, et al. Endoscopic submucosal dissection as total excisional biopsy for clinical T1 colorectal carcinoma. Digestion. 2015;91(1):64–9.

    Article  PubMed  Google Scholar 

  65. Saito Y, Sakamoto T, Nakajima T, Matsuda T. Colorectal ESD: current indications and latest technical advances. Gastrointest Endosc Clin N Am. 2014;24(2):245–55.

    Article  PubMed  Google Scholar 

  66. Kidane B, Chadi SA, Kanters S, Colquhoun PH, Ott MC. Local resection compared with radical resection in the treatment of T1N0M0 rectal adenocarcinoma: a systematic review and meta-analysis. Dis Colon Rectum. 2015;58(1):122–40.

    Article  PubMed  Google Scholar 

  67. Sajid MS, Farag S, Leung P, et al. Systematic review and meta-analysis of published trials comparing the effectiveness of transanal endoscopic microsurgery and radical resection in the management of early rectal cancer. Color Dis. 2014;16(1):2–14.

    Article  CAS  Google Scholar 

  68. Lu JY, Lin GL, Qiu HZ, et al. Comparison of Transanal endoscopic microsurgery and Total Mesorectal excision in the treatment of T1 rectal cancer: a meta-analysis. PLoS One. 2015;10(10):e0141427.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Clancy C, Burke JP, Albert MR, O’Connell PR, Winter DC. Transanal endoscopic microsurgery versus standard transanal excision for the removal of rectal neoplasms: a systematic review and meta-analysis. Dis Colon Rectum. 2015;58(2):254–61.

    Article  PubMed  Google Scholar 

  70. Hyun JH, Alhanafy MK, Park HC, et al. Initial local excision for clinical T1 rectal cancer showed comparable overall survival despite high local recurrence rate: a propensity-matched analysis. Ann Coloproctol. 2022;38(2):166–75.

    Article  Google Scholar 

  71. Bentrem DJ, Okabe S, Wong WD, et al. T1 adenocarcinoma of the rectum: transanal excision or radical surgery? Ann Surg. 2005;242(4):472–7. discussion 477–479

    Article  PubMed  PubMed Central  Google Scholar 

  72. Huang A, Zhao H, Ling T, et al. Oncological superiority of extralevator abdominoperineal resection over conventional abdominoperineal resection: a meta-analysis. Int J Color Dis. 2014;29(3):321–7.

    Article  Google Scholar 

  73. Negoi I, Hostiuc S, Paun S, Negoi RI, Beuran M. Extralevator vs conventional abdominoperineal resection for rectal cancer-a systematic review and meta-analysis. Am J Surg. 2016;212(3):511–26.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maggie L. Westfal .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Westfal, M.L., Mutch, M.G. (2023). Management of T1 Rectal Cancer. In: Umanskiy, K., Hyman, N. (eds) Difficult Decisions in Colorectal Surgery. Difficult Decisions in Surgery: An Evidence-Based Approach. Springer, Cham. https://doi.org/10.1007/978-3-031-42303-1_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-42303-1_21

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-42302-4

  • Online ISBN: 978-3-031-42303-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics